Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$605K Buy
6,416
+6,081
+1,815% +$656K 0.35% 65
2022
Q1
$41.6K Hold
335
0.01% 590
2021
Q4
$52.4K Sell
335
-501
-60% -$79.7K 0.01% 490
2021
Q3
$140K Sell
836
-65
-7% -$12.1K 0.03% 476
2021
Q2
$174K Sell
901
-1,408
-61% -$260K 0.04% 437
2021
Q1
$422K Buy
2,309
+574
+33% +$101K 0.12% 169
2020
Q4
$288K Buy
1,735
+829
+92% +$122K 0.08% 253
2020
Q3
$117K Sell
906
-639
-41% -$79.2K 0.03% 285
2020
Q2
$171K Buy
+1,545
New +$153K 0.05% 227
2018
Q4
Sell
-1
Closed -$75 727
2018
Q3
$75 Hold
1
﹤0.01% 632
2018
Q2
$81 Sell
1
-401
-100% -$31K ﹤0.01% 623
2018
Q1
$27.6K Buy
+402
New +$30.3K 0.01% 385

Other funds holding QRVO

Exane Derivatives's QRVO Position: Q2 2022 in Review

Exane Derivatives increased its Qorvo (QRVO) stake by 1,815% in Q2 2022, buying an estimated $656K and bringing the position to 6,416 shares worth $605K. The position accounts for 0.35% of the portfolio, ranked #65.

Exane Derivatives first reported a position in QRVO in Q1 2018 and has held it in 12 quarters since. 599 funds tracked by Wall St. Rank hold QRVO as of Q2 2022.

  • Exane Derivatives held 6,416 shares of Qorvo worth $605K as of Q2 2022.
  • Exane Derivatives bought 6,081 Qorvo shares in Q2 2022, an estimated $656K.
  • Qorvo made up 0.35% of Exane Derivatives's portfolio in Q2 2022, its #65 holding.
  • Exane Derivatives first reported a position in Qorvo in Q1 2018 and has held it in 12 quarters since.
  • 599 funds tracked by Wall St. Rank held Qorvo as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.